Community Research and Development Information Service - CORDIS

Horizon 2020 project information and now also report summaries are available on CORDIS. All H2020 projects can be downloaded from the EU Open Data Portal .

My refinements


Download results of this page


Refine by:

Programme

FP6
All
FP6-FOOD (1)
FP6-NMP (2)

Advanced search

Search projects and results

Results 1 - 10 of 19
Order by: Results/page:
12 > 
Chemical Food Safety Network for the enlarging Europe
ID: 513988
Start date: 2005-01-01, End date: 2006-12-31
Objectives of the project are to harmonise and integrate Associated Candidate Countries (ACC) and New Member States (NMS) infrastructures and activities in the field of chemical food safety with those of Member States (MS) and to provide the European Food Safety Authority (EFS...
Programme: FP6-FOOD
Record Number: 74168
Last updated on: 2013-03-26
SHARING EXPERIENCE ON RISK MANAGEMENT (HEALTH, SAFETY AND ENVIRONMENT) TO DESIGN FUTURE INDUSTRIAL SYSTEMS
ID: 505555
Start date: 2004-03-01, End date: 2007-02-28
SHAPE-RISK aims at optimising the efficiency of integrated risk management in the context of the sustainable development of the European process industry. The proposal addresses sustainable waste management and hazard reduction in production, storage and manufacturing. The mai...
Programme: FP6-NMP
Record Number: 74389
Last updated on: 2010-12-11
Worldwide remediation of mercury hazards through biotechnology
ID: 505561
Start date: 2004-03-01, End date: 2007-02-28
Mercury is a priority pollutant because of its extreme toxicity, global atmospheric transport and accumulation in the food chain. Its removal from current industrial emissions as well as from previously polluted sites is therefore mandatory and should take into account the lat...
Programme: FP6-NMP
Record Number: 74390
Last updated on: 2010-01-20
In vitro production of high quality mammalian oocytes for biotechnology, assisted reproduction, breeding and toxicology-teratology purposes
ID: QLK3-CT-1999-00104
Start date: 2000-02-01, End date: 2003-07-31
Our objective is to produce in vitro high quality mammalian oocytes for use in biotechnology, in assisted reproduction techniques, in preservation of genetic diversity, in production of high value added products through transgenesis, in farm animal breeding and in toxicology-...
Programme: FP5-LIFE QUALITY
Record Number: 51512
Last updated on: 2006-06-13
Multifunctional permeable barriers carrying well-performing microbial biofilms for treatment of mixed pollutant plumes
ID: QLK3-CT-2000-00163
Start date: 2001-01-01, End date: 2003-12-31
Groundwater polluted with complex mixtures of pollutants form a major threat for European drinking water resources. The permeable barrier technology is a sustainable in situ system to reduce risks associated with polluted water flowing in the direction of groundwater resources...
Programme: FP5-LIFE QUALITY
Record Number: 54286
Last updated on: 2006-06-13
Predicting outcome and developing new therapeutic strategies for haematological stem cell transplant recipients using in vitro techniques.
ID: QLK3-CT-2002-01936
Start date: 2003-01-01, End date: 2006-06-30
Allogeneic stem cell transplantation (SCT) is the only means of cure for haematological malignancies, as well as congenital anaemias and immunodeficiency disorders. The current poor rate of survival (30-50%) is due to post transplant complications, including infectious episode...
Programme: FP5-LIFE QUALITY
Record Number: 67231
Last updated on: 2005-12-09
Engineering yeast for efficient expression of heterologous membrane transporters
ID: QLK3-CT-2001-00533
Start date: 2002-01-01, End date: 2004-12-31
Expression of human proteins in a readily usable heterologous system is a powerful mean to study their function and structure and to discover novel targets and therapeutic routes directly associated with the causes of disease. Common yeast is ideal to adapt this technology to ...
Programme: FP5-LIFE QUALITY
Record Number: 64193
Last updated on: 2005-12-09
Blood grouping and genotyping : improving patient safety and blood transfusion compatibility
ID: QLK3-CT-2003-01772
Start date: 2003-06-01, End date: 2006-05-31
Currently, all blood utilised in transfusion is phenotype by serological means. As a consequence, blood is not phenotype for all clinically significant antigens and there is a real risk of patients becoming all immunised to incompatible blood units. The Blooded consortium prop...
Programme: FP5-LIFE QUALITY
Record Number: 70371
Last updated on: 2005-04-12
Prevalidation of novel alternative pharma-/toxicological screening based on yeast expression technology
ID: QLK3-CT-2001-00401
Start date: 2002-01-01, End date: 2005-06-30
The project aims to the revalidation of a novel alternative pharma-/toxicologicalscreening on potassium channels involved in human diseases based on yeast expression. Ion channels conduct the nerve impulses and mediate the effects of many signal molecules. Potassium (K) channe...
Programme: FP5-LIFE QUALITY
Record Number: 64343
Last updated on: 2005-04-12
Novel in vitro testing platforms based on intra-and extracellular sensing
ID: QLK3-CT-2001-00244
Start date: 2002-01-01, End date: 2004-12-31
The goal of the project is to develop new in-vitro platforms for pharmaceutical screening based on animal or human cells grown on microelectrode arrays enabling simultaneous monitoring of extra- and intracellular levels of key metabolites (e.g., NO and super oxide) by using op...
Programme: FP5-LIFE QUALITY
Record Number: 64198
Last updated on: 2005-04-12
12 > 
List retrieved on: 2018-01-21
Follow us on: RSS Facebook Twitter YouTube Managed by the EU Publications Office Top